Literature DB >> 31581287

Reply: Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.

Jesse C Thomas1, Ellen N Kersh1, Kim M Gernert1, William M Shafer2,3, Brian H Raphael1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 31581287      PMCID： PMC7768690          DOI： 10.1093/infdis/jiz505

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  2 in total

1.  Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.

Authors:  Jesse C Thomas; Sandra Seby; A Jeanine Abrams; Jack Cartee; Sean Lucking; Eshaw Vidyaprakash; Matthew Schmerer; Cau D Pham; Jaeyoung Hong; Elizabeth Torrone; Sancta St Cyr; William M Shafer; Kyle Bernstein; Ellen N Kersh; Kim M Gernert
Journal:  J Infect Dis       Date:  2019-06-19       Impact factor: 5.226

2.  Using the genetic characteristics of Neisseria gonorrhoeae strains with decreased susceptibility to cefixime to develop a molecular assay to predict cefixime susceptibility.

Authors:  Xiaomeng Deng; Lao-Tzu Allan-Blitz; Jeffrey D Klausner
Journal:  Sex Health       Date:  2019-09       Impact factor: 2.706
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.